[ad_1] Image source: Getty Images Many UK stocks are off to a good start in 2023. ASOS (LSE: ASC) share price, up 83% since the start of the year. To put that in perspective, we’re still looking at a 56%…
[ad_1] Apple Inc. (NASDAQ: AAPL ) this week reported its first decline in revenue in more than three years, even as high inflation continues to erode customers’ spending power. Sales of the flagship products of the gadget giant – the…
[ad_1] Image source: Getty Images Get the share price back above the 50p mark Lloyds (LSE:LLOY) is struggling to make it through 2022. However, it found a breakthrough in January as the bank’s shares are now up more than 10%…
[ad_1] Tyson Foods Inc. (NYSE: TSN ) was down 1% on Friday. The stock has fallen 27% over the past 12 months. The company is scheduled to report its first quarter 2023 earnings results on Monday, February 6th. Here’s what…
[ad_1] Image source: Getty Images We are very interested in this country house. It’s all about how to get your first mortgage or when to get on the property ladder. Property can be lucrative, and buy-to-let is a popular investment…
[ad_1] Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD ) reported an increase in net income for the fourth quarter of 2022 when revenue rose 2%. Revenue increased by 2% annually to $7.4 billion in the last three months of fiscal…
[ad_1] Image source: Getty Images A company that distributes income to its shareholders can be a good source of passive income. But dividend stocks can be tricky. Interest rates in the UK only reach 4%. That means investors can make…
[ad_1] Chipmaker Qualcomm, Inc. (NASDAQ: QCOM ) has reported lower revenue and profit for the first quarter of 2023. The company also provided guidance for the second quarter of 2023. At $9.5 billion, first-quarter revenue was down 12% from the…
[ad_1] Image source: Getty Images Yesterday seemed to be a meteoric rise Meta platform (NASDAQ:META) stock. After closing Wednesday at $153, Meta’s stock price ended Friday at $188.77, up more than 23%. The positive results released after the market closed…
[ad_1] Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) on Monday reported a decline in fourth-quarter earnings and adjusted earnings. Total revenue fell 31% year over year to $3.41 billion in the three months ending December 2022. However, excluding REGEN-COV and Ronapreve,…